Increased Asymmetric Dimethylarginine and Ischemia-Modified Albumin Levels in Obstructive Sleep Apnea

References

1. 1.↵
   1. Berry RB,
   2. Brooks R,
   3. Gamaldo CE,
   4. Harding SM,
   5. Lloyd RM,
   6. Marcus CL,
   7. et al

   . The AASM manual for the scoring of sleep and associated events: terminology and technical specifications, version 2.0.2. www.aasmnet.org. Darien, IL: American Academy of Sleep Medicine, 2013.
2. 2.↵
   1. Strohl KP,
   2. Brown DB,
   3. Collop N,
   4. George C,
   5. Grunstein R,
   6. Han F,
   7. et al

   . An official American Thoracic Society Clinical Practice Guideline: sleep apnea, sleepiness and driving risk in noncommercial drivers: an update of a 1994 statement. Am J Respir Crit Care Med 2013;187(11):1259–1266.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.
   1. Pack AI,
   2. Gislason T

   . Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009;51(5):434–451.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Bradley TD,
   2. Floras JS

   . Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373(9657):82–93.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Chowdhury M,
   2. Adams S,
   3. Whellan DJ

   . Sleep-disordered breathing and heart failure: focus on obstructive sleep apnea and treatment with continuous positive airway pressure. J Card Fail 2010;16(2):164–174.

   OpenUrlPubMed
6. 6.↵
   1. Bordier P

   . Sleep apnoea in patients with heart failure: part II: therapy. Arch Cardiovasc Dis 2009;102(10):711–720.

   OpenUrlPubMed
7. 7.↵
   1. Bhadriraju S,
   2. Kemp CR Jr.,
   3. Cheruvu M,
   4. Bhdriraju S

   . Sleep apnea syndrome: implications on cardiovascular diseases. Crit Pathw Cardiol 2008;7(4):248–253.

   OpenUrlPubMed
8. 8.↵
   1. Carlson JT,
   2. Rångemark C,
   3. Hedner JA

   . Attenuated endothelium dependent vascular relaxation in subjects with sleep apnoea. J Hypertens 1996;14(5):577–584.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Yildirim AO,
   2. Bulau P,
   3. Zakrzewicz D,
   4. Kitowska KE,
   5. Weissmann N,
   6. Grimminger F,
   7. et al

   . Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 2006;35(4):436–443.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Oettl K,
    2. Stauber RE

    . Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007;151(5):580–590.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Sbarouni E,
    2. Georgiadou P,
    3. Kremastinos DT,
    4. Voudris V

    . Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol 2008;49(4):260–266.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Dean RT,
    2. Wilcox I

    . Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993;16(8 Suppl):S15–S21; discussion S21-S22.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Yang LX,
    2. Ma SG,
    3. Liu H,
    4. Xu W

    . Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics 2013;68(7):968–973.

    OpenUrlPubMed
14. 14.↵
    1. Bar-Or D,
    2. Lau E,
    3. Winkler JV

    . A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia a preliminary report. J Emerg Med 2000;19(4):311–315.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Ohike Y,
    2. Kozaki K,
    3. Iijima K,
    4. Eto M,
    5. Kojima T,
    6. Ohga E,
    7. et al

    . Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure–possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005;69(2):221–226.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Gozal D,
    2. Kheirandish-Gozal L,
    3. Serpero LD,
    4. Sans Capdevila O,
    5. Dayyat E

    . Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007;116(20):2307–2314.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Barceló A,
    2. Piérola J,
    3. de la Peña M,
    4. Esquinas C,
    5. Sanchez-de la Torre M,
    6. Ayllón O,
    7. et al

    . Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 2012;39(4):913–918.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Hoyos CM,
    2. Melehan KL,
    3. Liu PY,
    4. Grunstein RR,
    5. Phillips CL

    . Does obstructive sleep apnea cause endothelial dysfunction? a critical review of the literature. Sleep Med Rev 2015;20:15–26.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Lavie L,
    2. Hefetz A,
    3. Luboshitzky R,
    4. Lavie P

    . Plasma levels of nitric oxide and l-arginine in sleep apnea subjects: effects of nCPAP treatment. J Mol Neurosci 2003;21(1):57–63.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Lavie L

    . Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed) 2012;4(1):1391–1403.

    OpenUrlPubMed
21. 21.↵
    1. Ozkan Y,
    2. Ozkan E,
    3. Simşek B

    . Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 2002;82(3):269–277.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Valkonen VP,
    2. Paiva H,
    3. Salonen JT,
    4. Lakka TA,
    5. Lehtimäki T,
    6. Laakso J,
    7. Laaksonen R

    . Risk of acute coronary events and serum concentration of asymmetric dimethylarginine. Lancet 2001;358(9299):2127–2138.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Ozkan Y,
    2. Firat H,
    3. Simşek B,
    4. Torun M,
    5. Yardim-Akaydin S

    . Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008;12(2):149–154.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Yüksel M,
    2. Okur HK,
    3. Pelin Z,
    4. Öğünç AV,
    5. Öztürk L

    . Arginase activity and nitric oxide levels in subjects with obstructive sleep apnea syndrome. Clinics 2014;69(4):247–252.

    OpenUrlPubMed
25. 25.↵
    1. Barceló A,
    2. de la Peña M,
    3. Ayllón O,
    4. Vega-Agapito MV,
    5. Piérola J,
    6. Pérez G,
    7. et al

    . Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in subjects with sleep apnea. Respiration 2009;77(1):85–90.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Borderie D,
    2. Allanore Y,
    3. Meune C,
    4. Devaux JY,
    5. Ekindjian OG,
    6. Kahan A

    . High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004;50(11):2190–2193.

    OpenUrlFREE Full Text
27. 27.↵
    1. Turedi S,
    2. Cinar O,
    3. Yavuz I,
    4. Mentese A,
    5. Gunduz A,
    6. Karahan SC,
    7. et al

    . Differences in ischemia-modified albumin levels between end stage renal disease subjects and the normal population. J Nephrol 2010;23(3):335–340.

    OpenUrlPubMed
28. 28.↵
    1. Ma SG,
    2. Wei CL,
    3. Hong B,
    4. Yu WN

    . Ischemia-modified albumin in type 2 diabetic subjects with and without peripheral arterial disease. Clinics 2011;66(10):1677–1680.

    OpenUrlPubMed
29. 29.↵
    1. Pantazopoulos I,
    2. Papadimitriou L,
    3. Dontas I,
    4. Demestiha T,
    5. Iakovidou N,
    6. Xanthos T

    . Ischaemia modified albumin in the diagnosis of acute coronary syndromes. Resuscitation 2009;80(3):306–310.

    OpenUrlPubMed
30. 30.
    1. Turedi S,
    2. Gunduz A,
    3. Mentese A,
    4. Topbas M,
    5. Karahan SC,
    6. Yeniocak S,
    7. et al

    . The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 2008;9:49.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Abboud H,
    2. Labreuche J,
    3. Meseguer E,
    4. Lavallee PC,
    5. Simon O,
    6. Olivot JM,
    7. et al

    . Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23(2):216–220.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Verma M,
    2. Dahiya K,
    3. Ghalaut VS,
    4. Soni A,
    5. Singh J,
    6. Dhupper V

    . Comparative study of ischemia modified albumin and nitric oxide in hyperthyroidism. J Invest Biochem 2014;3(1):17–20.

    OpenUrl